Frequency of GJB2 mutations in families with autosomal recessive non-syndromic hearing loss in Khuzestan province

Tahmasebi, Parisa; Hashemzadeh, Mohammad; Abdollahnejad, Fatemeh; Alavi, Zahra; Sadeghian, Ladan; Talebi, Farah; Mohammadi-Asl, Javad; Saki, Nader; Reza, Seyed; Amin, Mohammad Tabatabaiefar

doi:10.2298/gensr1803837t

Cited by 2 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 1 , 10 In addition to Azeri population, this variant is reported in Fars, Lur, and Kurdish 11 , 31 ethnicities. Nevertheless, this mutation was not identified among Baluchi, 28 , 40 Arab, 40 , 41 , 42 Gilaki, and Mazzani 2 , 11 population who live in the north and south of Iran.…”

Section: Discussionmentioning

confidence: 89%

GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran

Rodbaneh

Panahi

Rahimi

et al. 2021

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 89%

GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran

Rodbaneh

Panahi

Rahimi

et al. 2021

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles

Jin

Yao

Ying

et al. 2020

CTMC

View full text Add to dashboard Cite

: Incorporating nanotechnology into fluorescent imaging and magnetic resonance imaging (MRI) has shown promising potentials for accurate diagnosis of cancer at earlier stage than the conventional imaging modalities. Molecular imaging (MI) aims to quantitatively characterize, visualize, and measure the biological processes or living cells at molecular and genetic levels. MI modalities have been exploited in different applications including noninvasive determination and visualization of diseased tissues, cell trafficking visualization, early detection, treatment response monitoring, and in vivo visualization of living cells. High affinity molecular probe and imaging modality to detect the probe are the two main requirements of MI. Recent advances in nanotechnology and allied modalities, have facilitated the use of nanoparticles (NPs) as MI probes. Within the extensive group of NPs, fluorescent NPs play a prominent role in optical molecular imaging. The fluorescent NPs used in molecular and cellular imaging can be categorized into three main groups including quantum dots (QDs), upconversion, and dye-doped NPs. Fluorescent NPs have great potentials in targeted theranostics including cancer imaging, immunoassay based cells, proteins and bacteria detections, imaging-guided surgery and therapy. Fluorescent NPs have shown promising potentials for drug and gene delivery, detection of the chromosomal abnormalities, labeling of DNA, and visualizing DNA replication dynamics. Multifunctional NPs have been successfully used in a single theranostic modality integrating diagnosis and therapy. The unique characteristics of multifunctional NPs make them potential theranostic agents that can be utilized concurrently for diagnosis and therapy. This review provides state of the art of the nanotechnological applications for early cancer diagnosis focusing on fluorescent NPs, their synthesis methods and perspectives in clinical theranostics.

show abstract

Frequency of GJB2 mutations in families with autosomal recessive non-syndromic hearing loss in Khuzestan province

Cited by 2 publications

References 28 publications

GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran

GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran

Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles

Contact Info

Product

Resources

About